Egg harvesting for stem cell research: Medical risks and ethical problems

Reproductive BioMedicine Online

Volumn 13, Issue 4, 2006, Pages 573-579

  Beeson, Diane ^a   Lippman, Abby ^b  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Egg donation; Egg harvesting; Embryo cloning; Health risks; Ovarian hyperstimulation syndrome; Women's health

Indexed keywords

CLOMIFENE; DIETHYLSTILBESTROL; ESTROGEN; GANIRELIX; GONADOTROPIN; LEUPRORELIN; ORAL CONTRACEPTIVE AGENT; PROGESTERONE;

ARTICLE; CELL CLONING; CLINICAL TRIAL; DRUG APPROVAL; DRUG USE; HEALTH HAZARD; HUMAN; MEDICAL ETHICS; MEDICAL RESEARCH; OOCYTE; STEM CELL; UNSPECIFIED SIDE EFFECT;

EID: 33749675665     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60647-5     Document Type: Article

References (50)

1. Ahuja KK 1999 Money, morals and medical risks: conflicting notions underlying the recruitment of egg donors. Human Reproduction 14, 279-284.
2. Ahuja KK, Simons EG, Nair S et al. 2003 Minimizing risk in anonymous egg donation. Reproductive BioMedicine Online 7, 504-505.
3. Althuis MD, Moghissi KS, Westhoff CL et al. 2005 Uterine cancer after use of clomiphene citrate to induce ovulation. American Journal of Epidemiology 161, 607-615.
4. American Society of Reproductive Medicine (ASRM) 2005 Patient's fact sheet: side effects of gonadotropins. http://www.asrm.org/Patients/ FactSheets/Gonadatrophins-Fact.pdf [accessed 31 July 2006].
5. American Society of Reproductive Medicine (ASRM) Practice Committee 2003 Ovarian hyperstimulation syndrome. Fertility and Sterility 80, 1309-1314.
6. Andrews LB 2002 Genes and patent policy: rethinking intellectual property rights. Nature Reviews/Genetics 3, 803-808.
7. Bails J 2006 Pitt biologist trying to patent human cloning process. Pittsburg Tribute-Review. Jan. 7. http://www.pittsburghlive.com/x/ pittsburghtrib/s_411230.html [accessed 31 July 2006].
8. BBC News 2005/06/30 Safety of egg donation 'unclear'. http://news.bbc.co.uk/2/hi/health/4634625.stm [accessed 10 August 2006].
9. Bhattacharya S 2003 Stupidity should be cured, says DNA discoverer. NewScientist.com News Service http://www.newscientist.com/ article.ns?id=dn3451 [accessed 10 August 2006].
10. Brinton LA, Kamran S, Moghissi MD et al. 2005 Ovulation induction and cancer risk. Fertility and Sterility 83, 261-274.
11. CDC (Centers for Disease Control and Prevention) 2006 DES update: health care providers. http://www.cdc.gov/DES/hcp/index.html [accessed 31 July 2006].
12. Declaration of Geneva 1948 Adopted by the General Assembly of World Medical Association at Geneva Switzerland. http://www.cirp.org/library/ ethics/geneva/ [accessed 31 July 2006].
13. Delvigne A, Rozenberg S 2002 Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Human Reproduction Update 8, 559-577.
14. Dennis C 2006 Mining the secrets of the egg. Nature 439, 652-655.
15. Derek J 2004 Confessions of a Serial Egg Donor. Adrenaline Books, New York.
16. DES Action 2006 http://www.desaction.org [accessed 31 July 2006].
17. Hands Off Our Ovaries 2006 The hands off mission. http://www.handsoffourovaries.com/mission.htm [accessed 31 July 2006].
18. Hempel C 2006 Drowning in credit-card debt and student loans, young women are selling their eggs for big payoffs. But can they really make the right medical and moral decisions when they're tempted with $15,000? Boston Globe. June 25. http://www.boston.com/news/globe/ magazine/articles/2006/06/25/golden_eggs/ [accessed 31 July 2006].
19. Heng BC 2005 Ethical issues in paying for the long-distance travel and accommodation expenses of oocyte donors. Reproductive BioMedicine Online 11, 552-553.
20. Hugues N 2002 Ovarian stimulation for assisted reproductive technologies. In: Vayena E, Rowe PJ, Griffin PD (eds) Current Practices and Controversies in Assisted Reproduction. World Health Organization, Geneva, Switzerland, pp. 102-125.
21. Hwang WS, Roh SI, Lee BC, et al. 2005 Patient-specific embryonic stem cells derived from human SCNT blastocysts. Science 308, 1777-1783.
22. Hwang WS, Ryu YJ, Park JH, et al. 2004 Evidence of a pluripotent embryonic stem cell line derived from a cloned blastocyst. Science 303, 1669-1674.
23. Hwa-young TK 2006 Ova donors demand compensation from government. Asia News 2-7. http://www.asianews.it/view.php?1=en&art=5322 [accessed 10 August 2006].
24. International Society for Stem Cell Research (ISSCR) 2006 Guidelines for conduct of human embryonic stem cell research (draft 6-30-06). http://www.isscr.org/scientists/guidelines.cfm [accessed 10 August 2006].
25. Jensen D 2006 CIRM readying egg donor protections. California Stem Cell Report Jan. 1. http://californiastemcellreport.blogspot.com/ 2006_01_01_californiastemcellreport_archive.html [accessed 31 July 2006].
26. Kalfoglou AL, Gittelsohn J 2000 A qualitative follow-up study of women's experiences with oocyte donation. Human Reproduction 15, 798-805.
27. Kim T 2006 'Schatten stole Hwang's patent'. Korea Times [accessed 8 January 2006].
28. Lancet 2003 Editorial: Eggs shared, given and sold. Lancet 362, 413.
29. Lazar K 1999 Wonder drug for men alleged to cause harm in women. Boston Herald. [accessed 22 August 1999].
30. Magnus D, Cho MK 2005 Issues in oocyte donation for stem cell research. Science express http://www.sciencemag.org/cgi/reprint/308/5729/1747.pdf [accessed 31 July 2006].
31. Magureanu G 2005 Letter to European Parliament. June 30. http://www.handsoffourovaries.com/pdfs/appendixg.pdf [accessed 14 August 2006].
32. National Academies of Sciences 2005 Guidelines for human embryonic stem cell research. Committee on Guidelines for Human Embryonic Stem Cell Research and National Research Council http://www.nap.edu/catalog/ 11278.html [accessed 31 July 2006].
33. Ness RB, Cramer DW, Goodman MT 2002 Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. American Journal of Epidemiology 155, 217-224.
34. Newman SA 2003 Averting the clone age: prospects and perils of human developmental manipulation. Journal of Contemporary Health Law and & Policy 431-463. http://thehumanfuture.org/commentaries/ newman_averting.pdf [accessed 10 August 2006].
35. Norsigian J 2005 Stem cell research and embryo cloning: involving laypersons in the public debates. New England Law Review 39, 527-534.
36. Papadimos TJ, Papadimos AT 2004 The student and the ovum: the lack of autonomy and informed consent in trading genes for tuition. Reproductive Biology and Endocrinology 2, 56.
37. Parisian S 2005 Open Letter. http://www.genetics-and-society.org/ resources/items/200502_letter_parisian.html [accessed 31 July 2006].
38. Pearson H 2006 Health effects of egg donation may take decades to emerge. Nature Magazine 442, 607-608. http://www.genetics-and-society.org/resources/items/ 20060810_nature_pearson.pdf [accessed 10 August 2006].
39. Reynolds J, Darnovsky M 2006 The California Stem Cell Program at One Year: A Progress Report. Oakland, CA: The Center for Genetics and Society.
40. Rossing MA, Daling, JR, Weiss NS, et al. 1994 Ovarian tumors in a cohort of infertile women. New England Journal of Medicine 331, 771-776.
41. Sexton S 2005 Transforming 'waste' into 'resource': from women's eggs to economics for women. Paper presented at Femme Globale Conference. http://www.thecornerhouse.org.uk/pdf/document/eggs.pdf [accessed 31 July 2006].
42. Steigenga MJ, Helmerhorst FM, DE Koning J et al. 2006 Evolutionary conserved structures as indicators of medical risk: increased incidence of cervical ribs after ovarian hyperstimulation in mice. Animal Biology 56, 63-68.
43. Steinbrook R 2006 Egg donation and human embryonic stem-cell research. New England Journal of Medicine 354, 324-326.
44. Snyder EY, Loring JF 2006 Beyond fraud - stem-cell research continues. New England Journal of Medicine 354, 321-324.
45. Spar D 2006 The Baby Business: How Money, Science, and Politics Drive the Commerce of Conception. Boston, USA: Harvard Business School Press.
46. Tilghman S 2004 Address to the Stem Cell Institute of New Jersey. Presented at the Inaugural Symposium, the Stem Cell Institute of New Jersey, November 11 2004. http://www.princeton.edu/president/speeches/ 20041111/index.xml [accessed 31 July 2006].
47. Whittemore AS, Harris R, Itnyre J et al. 1992 Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. American Journal of Epidemiology 136, 1184-1203.
48. Women's Health Initiative Steering Committee 2004 Effects of conjugated equine estrogen in postmenopausal women with hysterectomy - the women's health initiative randomized controlled trial. Journal of the American Medical Association 291, 1701-1712.
49. World Medical Association 1949 International code of medical ethics of the World Medical Association - 1949. World Medical Association Bulletin 1, 109-111. http://www.cirp.org/library/ethics/intlcode/ [accessed 31 July 2006].
50. Writing Group for the Women's Health Initiative Investigators 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women, principal results from the Women's Health Initiative randomized controlled trial. Journal of the American Medical Association 288, 321-333.